drugset / Trial / NCT05995704

Evaluation of Apraglutide on Gastric Emptying

NCT05995704

Phase 1 Completed 42 enrolled VectivBio AG
RandomizedParallel-groupQuadruple-blindOther

Summary

The primary objective is to assess the effect of apraglutide on gastric emptying of liquids in healthy subjects, as measured by the PK of acetaminophen mixed with a liquid meal.

Timeline

Start
2023-03-02
Primary completion
2023-07-24
Completion
2023-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule
Subject Apraglutide Peptide Subcutaneous

Indications

No indication recorded.